ArticleJournal of pain research2026
Serratus Posterior Superior Intercostal Plane Block and Serratus Anterior Plane Block Compared with Conventional Analgesia for Postoperative Analgesia in Breast Cancer Surgery: A Randomized Controlled Trial.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The aim of this study was to compare the analgesic efficacy and recovery outcomes of the serratus posterior superior intercostal plane block (SPSIPB) and the serratus anterior plane block (SAPB) with conventional analgesia in patients undergoing oncoplastic breast surgery. Patients and Methods: One hundred and five patients aged 18-65 years with an ASA physical status of I-III were included in this prospective, randomized controlled study. Patients were randomly assigned in a 1:1:1 ratio to three groups: the Control Group, the SPSIPB Group, and the SAPB Group. Outcome assessors were blinded to group allocation. The primary outcome was cumulative tramadol consumption during the first 24 h postoperative. Secondary outcomes included Numeric Rating Scale (NRS) scores at rest and during activity, Quality of Recovery-15 (QoR-15) scores, and the incidence of postoperative nausea and vomiting (PONV). Results: Cumulative tramadol consumption during the first 24 h was significantly lower in the SPSIPB and SAPB groups compared with the Control Group (p < 0.001), with no significant difference between the two block groups. Although NRS pain scores were comparable among groups at all time points, QoR-15 scores were significantly higher and antiemetic requirements were lower in both block groups compared with the Control Group. Conclusion: The SPSIPB and SAPB reduced opioid consumption and improved quality of recovery compared with conventional management, despite similar pain scores, with no significant difference between the two techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.